Live Breaking News & Updates on முதலீடு இல் ரஃபேல் மருந்துகள்

Stay updated with breaking news from முதலீடு இல் ரஃபேல் மருந்துகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Rafael Holdings Reports Second Quarter Fiscal Year 2021 Results


Rafael Holdings Reports Second Quarter Fiscal Year 2021 Results
News provided by
Share this article
Share this article
NEWARK, N.J., March 17, 2021 /PRNewswire/  Rafael Holdings, Inc., (NYSE: RFL), reported revenue of $1.0 million and a loss per share of $0.50 for the second quarter of its 2021 fiscal year, the three months ended January 31, 2021.
Q2 FY 2021 Consolidated Financial and Operational Highlights
Revenue of $1.0 million, generated by Rafael Holdings real estate portfolio, decreased from $1.2 million in the year-ago quarter due, in part, to the sale of its building in Piscataway, NJ.
Loss per share of $0.50 compared to a loss per share of $0.08 in the year ago quarter primarily due to a $7.0 million impairment of the company s interest in Altira, as described below. ....

United States , Howard Jonas , Fordoz Pharma , Joshua Rabinowitz , Third Party , Sarcoma Alliance For Research , Lipomedix Pharmaceuticals Ltd , Rafael Pharmaceuticals , Princeton University Office Of Technology Licensing , Rafael Holdings Inc , Barer Institute , Rafael Pharmaceuticals Inc , Investment In Rafael Pharmaceuticals , Rp Finance , Rafael Holdings , Drug Administration , Rafael Holding , Department Of Chemistry , Company Class , Other Pharmaceuticals , Rafael Holding Board Of Directors , Holding Board , Ameet Mallik , Chief Executive Office , Rafael Holding Chief Commercial , Rafael Pharmaceutical ,